Stay updated with breaking news from Michael Erman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration said on Tuesday it was investigating cancer therapies made by Gilead Sciences, Johnson & Johnson, Novartis and others over the risk of hospitalizations and...
Pfizer Inc is disappointed in its performance versus rival GSK in the RSV vaccine market and is working to pick up market share in 2024, Chief Financial Officer David Denton said on Tuesday. ...
(Reuters) -The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies made by companies such as Gilead Sciences, Johnson & Johnson and Novartis over the risk of hospitalizations and death due to a serious safety issue. The FDA said it had received reports of T-cell malignancies, which refer to a group of blood disorders including lymphomas and leukemias, after treatment with CAR-T therapies or chimeric antigen receptor T-cell therapies. Since 2017, six CAR T-cell therapies have been approved by the FDA and all are for the treatment of blood cancers...
Over 15 million people in the United States, around 4.5% of the population, had received the updated COVID-19 shots by October 27, lagging behind last year's vaccinations.
WASHINGTON (Reuters) -Over 15 million people in the United States, around 4.5% of the population, had received the updated COVID-19 shots by Oct. 27, a Department of Health and Human Services (HHS) spokesperson said on Wednesday, lagging behind last year's vaccinations. Close to 23 million people had received updated boosters as of Oct. 26 last year, U.S. Centers for Disease Control and Prevention (CDC) data shows. "As of Oct. 27, more than 15 million Americans have received the updated COVID-19